3 ms·
Yeah, maybe then testing for this marker could be done concurrently with the PCR test for Covid, and the tested person can receive a warning that they are likel
by rob74 5y ago
Yeah, maybe then testing for this marker could be done concurrently with the PCR test for Covid, and the tested person can receive a warning that they are likely to get a severe case - or the presence of this biomarker may even be used to give them priority for treatment with monoclonal antibodies or other treatment methods? The next question is of course: how do vaccines get into play? AFAIK they protect you from getting a severe case most of the time, even if you have this marker/lung damage?
Anyway, that's one way having this marker might turn out to be useful - otherwise it only confirms what was already known, that patients with preexisting lung damage are more likely to have a severe case. Of course, patients or their doctors may not be aware of the lung damage or underestimate it, while the marker is more objective...
- boibombeiro 5y agoIntuitively, it dosent seems to be a good idea. We should hear what someone with strong Bayesian statistics knowledge think about this. But running tests on many people to do individual prognostic is usually a terrible idea.